Skip to content
Screener

BioLife Solutions BLFS Total Current Assets

Total Current Assets at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
$23.37B-5.0%
Danaher logo
DanaherDHR
$13.38B+21.7%
Azenta logo
AzentaAZTA
$681.35M
TEC
Bio-TechneTECH
$688.05M+9.7%
Revvity logo
RevvityRVTY
$2.13B-8.2%
CryoPort, Inc. logo
CryoPort, Inc.CYRX
$460.2M-6.0%

Other financials

Income statement

See full
Revenue$28.5M+21.5%
Gross profit$18.3M+20.0%
Operating income$1.7M+111%
Net income$45.1M+385%
EPS (diluted)$0.91+376%

Balance sheet

See full
Cash & equivalents$24.0M-24.8%
Total debt$15.7M-33.9%
Total equity$420.0M+21.0%
Total assets$447.5M+15.6%

Cash flow

See full
Operating cash flow$6.3M-13.8%
CapEx$1.0M-40.2%
Free cash flow$5.3M-5.7%

Valuation

See full
Market cap$1.66B+64.3%
Enterprise value$1.65B+64.8%
P/E53.4×
P/S16.1×+3.8×

Profitability

See full
Gross margin67.2%
Operating margin1.6%
Net margin-68.7%
FCF margin-15.9%+18.7pp

Returns & leverage

See full
Return on equity-14.5%-4.7pp
Debt / equity0.0×
Current ratio9.7×+5.3×

Where this comes from

Reported directly by BioLife Solutions in its filing.

Tagged under the XBRL concept us-gaap:AssetsCurrent.

The source filing: BioLife Solutions’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 4:22 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-054355
(In thousands, except per share and share data)June 30, 2026December 31, 2025
Accounts receivable, trade, net of allowance for credit losses of $16 and $22 as of June 30, 2026 and December 31, 2025, respectively10,6527,953
Inventories35,59130,155
Prepaid expenses and other current assets6,5399,526
Total current assets135,198136,561
Property and equipment, net15,23514,713
Operating lease right-of-use assets, net8,6447,466
Other assets3,2893,050
Available-for-sale securities, long-term30,65431,250

Item 1. Unaudited Condensed Consolidated Financial Statements

FAQ

What is BioLife Solutions's total current assets?
BioLife Solutions (BLFS) reported total current assets of $135.2M in Q2 2026.
How has BioLife Solutions's total current assets changed year-over-year?
BioLife Solutions's total current assets increased by 7.8% year-over-year, from $125.43M to $135.2M.
What is the long-term trend for BioLife Solutions's total current assets?
Over 5 years (2020 to 2025), BioLife Solutions's total current assets has grown at a 3.5% compound annual growth rate (CAGR), from $114.71M to $136.56M.
What does total current assets mean?
The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.

Ask your AI about BioLife Solutions's total current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude